baber/WOPTO huggingface dataset:
Patent JP-3188694-B2 (JP)
IPC: A43B23/02
Filed: 1991-06-07
Granted: 2001-07-16
Abstract: Items of footwear are described, in particular a multi-purpose shoe comprising in a mutually mobile arrangement a calcanean shell (17) and a leg (22) for supporting the ankle, via a deformable talocalcanean section (21) which at least partially surrounds the foot around the talocalcanean joint in order to at least partially accommodate the eversion and inversion movements of the ankle. Applications: sports or rehabilitation footwear.
Patent JP-3210675-B2 (JP)
IPC: H05K3/24
Filed: 1995-10-18
Granted: 2001-09-17
Abstract: A process for depositing metal coatings on polyimide surfaces for producing conductor tracks includes depositing a first metal coating by decomposition of volatile metal compounds by a glow discharge in a gas mixture containing inert gases and oxygen containing compounds, followed by electroless deposition of a second metal coating from an acid or neutral metallizing bath.
Patent JP-3222134-B2 (JP)
IPC: C04B35/48
Filed: 1991-08-05
Granted: 2001-10-22
Abstract: Zirconium dioxide containing 2 to 40 vol. % of stabilizing oxides is embedded in the matrix material of a sintered moulding consisting of an aluminium oxide/chromium oxide mixed crystal. The quantity of stabilizing oxides added is chosen so that the zirconium dioxide is predominantly tetragonal. The molar ratio of the zirconium dioxide containing the stabilizing oxides to the chromium oxide is between 1000 : 1 and 20 : 1 and the zirconium dioxide has a maximum particle size of 2  mu m.
Patent JP-3559280-B2 (JP)
IPC: A61K31/23
Filed: 1993-02-23
Granted: 2004-08-25
Abstract: PCT No. PCT/SE93/00146 Sec. 371 Date Oct. 21, 1994 Sec. 102(e) Date Oct. 21, 1994 PCT Filed Feb. 23, 1993 PCT Pub. No. WO93/16691 PCT Pub. Date Sep. 2, 1993The present invention relates to omega-3-fatty acid containing preparations for the treatment of Disseminated Intravascular Coagulation (DIC) and symptoms related to DIC, as well as such preparations for reducing a pathological increase in pulmonary artery pressure (PAP). The preparations may be in the form of emulsions, or aerosols for inhalation, of an oil or phospholipids or other derivatives or salts of omega-3-fatty acids of marine and/or vegetable origin with a significant content of omega-3-fatty acids. The preparations may also be in tablet or capsule form for oral use.
Patent JP-3712418-B2 (JP)
IPC: A61B5/022
Filed: 1996-10-03
Granted: 2005-11-02
Abstract: A monitor (120) determining a patient's physical condition includes a calibration device (104) configured to provide a calibration signal representative of a patient's physiological parameter. An exciter (202) is positioned over a blood vessel of the patient for inducing a transmitted exciter waveform into the patient. A noninvasive sensor (210) is positioned over the blood vessel, where the noninvasive sensor is configured to sense a hemoparameter and to generate a noninvasive sensor signal representative of the hemoparameter containing a component of a physiological parameter waveform and a component of a received exciter waveform. In this context, a hemoparameter is defined as any physiological parameter related to vessel blood such as pressure, flow, volume, velocity, blood vessel wall motion, blood vessel wall position and other related parameters. A processor (100) is configured to determine a relationship between a property of the received exciter waveform and a property of the physiological parameter. The processor is connected to receive the calibration signal and the noninvasive sensor signal, and the processor is configured to process the calibration signal and the noninvasive sensor signal to determine the physical condition. In an exemplary embodiment, the physical condition is arterial stiffness that represents cardiovascular disease, however, many additional physical conditions can be measured and determined such as arterial elasticity, arterial thickness, arterial wall compliance and other conditions. Also, in an exemplary embodiment, the physiological parameter measured is blood pressure, however, the present invention can also be used to analyze and track other physiological parameters.
Patent JP-3115597-B2 (JP)
IPC: C07D471/10
Filed: 1991-10-10
Granted: 2000-12-11
Abstract: This invention relates to alkylidene analogs of 1'-aminospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrones, represented by formula (I):    <IMAGE>  (I)  to processes for the preparation, to methods for using the compounds, and to pharmaceutical preparations thereof. The compounds have pharmaceutical properties which render them beneficial for the prevention or treatment of diabetes mellitus associated complications.
Patent JP-4001350-B2 (JP)
IPC: A61L15/60
Filed: 1996-11-18
Granted: 2007-10-31
Abstract: The present invention relates to superabsorbent cross-linked polymers for watery liquids, which are built-up of partially neutralized monomers having monoethylenlcally unsaturated acid groups, optionally further monomers copolymerizable therewith, as well as polymers optionally suitable as graft basis, and which can be manufactured by using a cross-linker/monomer combination of CH2=CHR6-CO-(OCHR3-CHR3)zO-CH2-CHR6=CH2 CH2=CHR6-R5-(OCHR3-CHR3)vOR4 R1-[O(CHR3-CHR3O)u-CO-R2]x, and/or di- or triallylamine and/or bisacrylamidewith R1: multivalent C2-10-alkyl, R2: linear or branched C2-10-alkenyl, R3: H, CH3, C2H5, R4: H, linear or branched C1-10-alkyl, R6: CO, CH2R8: H, CH3x: 2-6 u: 0-15 V: 1-45 z: 3-20 As compared with the state of the art, the polymers according to the present invention have an improved combination of the properties retention, liquid absorption under pressure at 63 g/cm2 and soluble contents, moreover, they have an Increased permeability of the gel layer for watery liquids, a high suction rate, and a high swelling pressure. The polymers are used as absorbents for water and watery liquids in constructions for the absorption of body fluids, In electricity or light-conducting cables, and in plant raising.
Patent JP-3103596-B2 (JP)
IPC: B01F23/10
Filed: 1994-03-07
Granted: 2000-10-30
Abstract: A process system comprising a liquid reagent vaporization and supply apparatus (300) including a vaporization chamber housing (302) having a porous vaporization element (340) therein in proximity to the housing interior wall surface (320) to define liquid flow channels (332, 324, 326, 328). A pump assembly (10) may be used in such system to pump air- or moisture-sensitive liquids, in which the wetted parts of the pump are blanketed with an inert medium and/or the process liquid with a low vapor pressure liquid component effective for inhibiting corrosion or particulate formation. In another aspect, the invention relates to a means and method for protecting a source reagent vaporizer (17) from the harmful effects of solid build-up occurring during its use in chemical vapor deposition (CVD), due to premature decomposition of the source reagent on the vaporizer element and oxidative decomposition of the source reagent to produce solid products which cause clogging and inefficient vaporization, by periodically flush cleaning such vaporizer element to increase its consistency, reliability, and service life.
Patent JP-3836874-B2 (JP)
IPC: A61K39/39
Filed: 1995-01-11
Granted: 2006-10-25
Abstract: The present invention features an adjuvanted vaccine, and methods for preparing an adjuvanted vaccine, preferably for immunizing against influenza, where the adjuvant is a lipid vesicle, and preferably is a nonphospholipid, paucilamellar lipid vesicle. The antigen may be encapsulated in the central cavity of the adjuvant, or mixed in solution with the adjuvant. Moreover, the adjuvant may carry a secondary adjuvant to further improve the immune response.
Patent JP-4050795-B2 (JP)
IPC: C08G59/18
Filed: 1998-03-04
Granted: 2008-02-20
Abstract: The invention relates to a binder (A) in aqueous dispersion which is obtainable by neutralization of the tertiary amino groups of an amino-epoxy resin a1) with acid and reaction of the resulting product with a polyepoxide a2) to form quaternary ammonium groups and conversion into an aqueous dispersion with water. The invention furthermore relates to a process for the preparation of binders (A) in aqueous dispersion and their use in cathodic electrodeposition lacquers.
Patent JP-3842300-B2 (JP)
IPC: B23G5/06
Filed: 1998-04-03
Granted: 2006-11-08
Abstract: A thread-producing tool for producing an internal thread includes a body forming a rear shank portion and a front cutting portion. Provided in the body is a lubricant storage chamber for storing liquid lubricant which is driven toward the cutting portion through discharge passages under the action of centrifugal force during a thread-cutting operation.
Patent JP-5118790-B2 (JP)
IPC: A61K49/00
Filed: 1998-04-02
Granted: 2013-01-16
Abstract: The invention relates to acid-labile and enzymatically divisible compounds for in-vivo and in-vitro diagnosis by means of near infrared radiation (NIR-radiation), the use of said compounds as optic diagnostic and therapeutic agents, and the diagnostic agents containing said compounds.
Patent JP-4484970-B2 (JP)
IPC: F16D11/14
Filed: 1998-02-12
Granted: 2010-06-16
Abstract: The invention concerns a morphology matrix for forming the cross-sectional shape of a short gearing tooth, in particular on toothed wheels of motor vehicle gearboxes. The short gearing teeth are formed on a cylindrical section of a gear wheel or gear shift sleeve, the axis of this section coinciding with the displacement axis of the gear shift sleeve. Each tooth comprises a tip which is chamfered in roof-like manner and has lateral flanks (3) which are shaped towards the tooth base (1) so that they have a relief at least over part of their height. The lateral flanks (3) terminate in a radiused tooth base (4), all of the teeth, or some thereof defined according to a regularly changing pattern, having at least a morphology defining the shape of the lateral flanks.
Patent JP-3781436-B2 (JP)
IPC: H04L12/801
Filed: 1998-10-20
Granted: 2006-05-31
Abstract: Method for random-access communication in communication networks (1) with time-slotted transmission channels which are being accessed by a plurality of terminal devices (2), whereby the terminal devices (2) are provided with binary feedback (S/{overscore (S)}) by a common receiver (3), a positive feedback (S) indicating that a particular slot contained a successfully transmitted packet or a negative feedback ({overscore (S)}) indicating that the particular slot did not contain a successfully transmitted packet, and whereby dummy packets are transmitted by an auxiliary user (4) following the first negative feedback ({overscore (S)}) after a prior collision has been resolved to determine whether said negative ({overscore (S)}) feedback was due to a collision of packets in the respective slot or whether it was due to this slot having been empty.Unsuccessfully transmitted packets are re-transmitted in accordance with their respective position in an interval, which position is determined by the numeric value of a parameter assigned to each packet, which interval is divided into two portions by a predefined parameter (alpha), and which numeric values are randomized after a negative feedback ({overscore (S)}) occurred during the resolution of a collision.
Patent ES-2322016-B2 (ES)
Title: Procedimiento de detoxificacion del agua de lixiviacion cianurada de mina.
Inventor: SANCHO MARTINEZ JOSE PEDRO
IPC: C02F1/72
Filed: 2008-09-17
Granted: 2010-02-08
Abstract: Procedimiento de detoxificación del agua de
lixiviación cianurada de mina  que comprende una fase inicial de
alcalinización mediante el empleo de  un reactivo básico, una
segunda fase de aireación y oxigenación, una tercera  fase de
tratamiento con permanganato potásico y nitrato de plata y una  fase
final de floculación y decantación. 
     De aplicación en sectores como el medioambiental
o en las industrias extractivas.
Patent ES-2345090-B2 (ES)
Title: Sistema de control para la eliminacion biologica de nitrogeno de aguas residuales mediante sondas de bajo coste.
Inventor: FERRER POLO JOSE
IPC: C02F3/30
Filed: 2009-03-13
Granted: 2011-01-27
Abstract: Sistema de control para la eliminación biológica
de nitrógeno de aguas residuales mediante sondas de bajo coste. La
presente invención describe un sistema de control, basado en la
lógica difusa, que permite optimizar la eliminación biológica de
nitrógeno en procesos en continuo de tipo predesnitrificación con
régimen de circulación de flujo de pistón o en reactores de mezcla
completa. Si los reactores son de tipo mezcla completa deben
disponer de al menos dos zonas diferenciadas aerobias y dos zonas
diferenciadas anóxicas. Cuando se trata de reactores de tipo flujo
de pistón no es necesaria esta diferenciación dentro de cada tipo de
reactor (anóxico y aerobio). Este sistema de control está basado en
el uso de sondas de bajo coste de tipo pH y ORP.
Patent ES-2668419-B2 (ES)
Title: Pasta modelable compuesta por fibra de papel, aglutinante líquido, material cementante en polvo, y agua, modelable, no tóxica y fácil de manipular
Inventor: DE TORRES DOMINGUEZ DÁMIAN
IPC: C04B38/10
Filed: 2016-11-17
Granted: 2018-09-06
Abstract: Se trata de una pasta modelable compuesta por fibra de papel, aglutinante líquido, material cementante en polvo y agua, modelable, no tóxica y fácil de manipular.
Patent AU-2000270582-B2 (AU)
Title: Foam/film composite medical articles
Inventor: SWENSON MARY M
IPC: A61L15/42
Filed: 2000-08-11
Granted: 2005-06-30
Abstract: A medical article comprising a backing, an absorbent, substantially nonswellable foam and an adhesive disposed therebetween.
Patent AU-2001270250-B2 (AU)
Title: Episodic delivery of content
Inventor: MOORE RICHARD EVANS
IPC: A63F13/12
Filed: 2001-06-26
Granted: 2005-01-27
Abstract: A system, method, and apparatus are provided that allow episodic delivery of entertainment content to a user. More specifically, an application module is created with episodic content technology, which can be purchased as a CD-ROM or downloaded from a remote server. The application module contains a current episode of the game and a technology shell to allow future episodes to be downloaded and executed. The entertainment content delivery system is implemented through a centralized server that provides new episodes of the content available for downloading at regularly scheduled intervals to the users' computers. The current instantiation of the application module segregates technology components from content components of the application module to allow independent modification of either. Technological advancements are incorporated as they occur into the new episodes and are executed by the application module. An Internet-enabled game using the entertainment content delivery system communicates with users through various mechanisms, including e-mail, voice mail, fax machines, web sites, and the like.
Patent AU-2001280096-B2 (AU)
Title: Polypeptides controlling phosphoric acid metabolism, calcium metabolism, calcification and vitamin D metabolism and DNAs encoding the same
Inventor: FUKUMOTO SEIJI
IPC: A61P35/00
Filed: 2001-08-10
Granted: 2007-03-22
Abstract: A DNA, which encodes the following polypeptide (a), (b), (c) or (d): 
(a) a polypeptide consisting of an amino acid sequence represented by SEQ ID NO: 2 or 4, 
(b) a polypeptide consisting of an amino acid sequence derived from the amino acid sequence represented by SEQ ID NO: 2 or 4 by deletion, substitution or addition of one or several amino acids, and having hypophosphatemia-inducing activity, phosphate transport-suppressing activity, calcification-suppressing activity or in vivo vitamin D metabolism-regulating activity, 
(c) a polypeptide consisting of a partial sequence of the amino acid sequence represented by SEQ ID NO: 2, wherein the above partial sequence contains an amino acid sequence at least ranging from the 34 th  to 201 st  amino acids in the above amino acid sequence, or 
(d) a polypeptide consisting of a partial sequence of the amino acid sequence represented by SEQ ID NO: 2, wherein the above partial sequence: 
(i) contains an amino acid sequence ranging from at least the 34 th  to 201 st  amino acids in said amino acid sequence, 
(ii) consists of an amino acid sequence derived from the partial sequence by deletion, substitution, or addition of one or several amino acids, and 
(iii) has hypophosphatemia-inducing activity, phosphate transport-suppressing activity, calcification-suppressing activity or in vivo vitamin D metabolism-regulating activity.
Patent AU-2002222206-B2 (AU)
Title: Henna product
Inventor: CONSTANTINE MARGARET
IPC: A61K8/31
Filed: 2001-12-13
Granted: 2006-09-07
Abstract: A product comprising as its main components henna and cocoa butter with the product having a solid form. Also a method of forming a solid form product comprising the step of mixing henna and cocoa butter to form a paste and allowing the paste to harden. Additives may be provided, such as a surfactant, a conditioning agent, a fragrance, a herb, a fruit extract, a vegetable, a natural way or butter, a synthetic wax, a humectant, glycerine, a vegetable oil. Preferably, the product is form of 40% to 90% henna by weight and 10% to 60% cocoa butter by weight. More preferably the product is formed of 60% to 80% henna by weight and 20% to 40% cocoa butter by weight. Most preferably the product is formed of 70% henna by weight and 30% cocoa butter by weight.
Patent AU-2002316426-B2 (AU)
Title: A system and method for assessing urinary function
Inventor: NOHILLY MARTIN
IPC: A61B5/20
Filed: 2002-06-27
Granted: 2007-04-26
Abstract: A method is provided for assessing urinary function including removably coupling a first test module to a portable control device, selecting from a plurality of different tests a first test to assess urinary function, the selection being made based on first module identification information obtained by the control device from the test module, and performing the first test. The method may also include one or more of the steps of inserting an insert member coupled to the first test module at least partially into a patient's urinary tract, infusing fluid through the insert member into the urinary tract, and measuring pressure within the urinary tract as fluid is infused therein. The method may further include uncoupling the first test module from the portable control device, coupling a second test module to the portable control device, selecting a second test to assess urinary function based on second module identification information obtained by the control device from the second test module, and performing the second test.
Patent AU-2002328605-B2 (AU)
Title: Retroreflection device
Inventor: MIMURA IKUO
IPC: E01F9/619
Filed: 2002-08-09
Granted: 2007-04-05
Abstract: The first reflective lateral face of the first triangular-pyramidal retroreflective unit is on the same plane with the first lateral face of the tetrahedral retroreflective unit, the second reflective lateral face of the first triangular-pyramidal retroreflective unit is on the same plane with the second lateral face of the tetrahedral retroreflective unit, the third reflective lateral face of the first triangular-pyramidal retroreflective unit is parallel to one of the two lateral faces forming a V shaped groove, the third reflective lateral face of the second triangular-pyramidal retroreflective unit is identical with, or parallel to, the other of the two faces forming said V-shaped groove; and the third reflective lateral face of said tetrahedral retroreflective unit is same as one of the two faces forming said V-shaped groove. <IMAGE>
Patent AU-2002332099-B2 (AU)
Title: Imidazole derivates as antiinflammatory agents
Inventor: FRENKEL ALEXANDER DAVID
IPC: C07D401/06
Filed: 2002-10-09
Granted: 2007-12-13
Abstract: Compounds, pharmaceutical compositions and methods are provided that are useful in the treatment of inflammatory and immune-related conditions or disorders. In particular, the invention provides compounds which modulate the expression and/or function of proteins involved in inflammation, immune response regulation and cell proliferation. The subject compounds are 2-amino-imidazole derivatives.
Patent AU-2003276089-B2 (AU)
Title: Modular antigen transporter molecules (mat molecules) for modulating immune reactions, associated constructs, methods and uses thereof
Inventor: LAMPING NORBERT
IPC: A61K39/00
Filed: 2003-10-09
Granted: 2009-09-17
Abstract: A modular antigen-transporting molecule (MAT) comprising one each of a translocation module (TrM), a targeting module (TaM) and an antigen module (AM), is new.  Modular antigen-transporting molecule (MAT) comprising at least one each of translocation module (TrM), targeting module (TaM) and antigen module (AM) is new. TrM is able to transport MAT from the extracellular space into a cell; TaM directs transport of MAT to organelles involved in processing of antigens (Ag) or loading of MHC (major histocompatibility complex) molecules, and AM determines the specificity of the immune response induced by MAT.  Independent claims are also included for the following: (1) method for preparing MAT;  (2) nucleic acid (I) that encodes MAT;  (3) vector containing (I) and preferably at least one of promoter, antibiotic or antimycotic resistance gene;  (4) primary cells or cell lines containing a vector of (3) or (I);  (5) vesicles, especially exosomes, deoxosomes or liposomes that contain at least one MAT, (I) or the vector of (3);  (6) immunoglobulins (Ig), or their fragments, that recognize MAT, prepared by immunization of a human or animal;  (7) method for identifying substances that inhibit or stimulate presentation of Ag through the MHC;  (8) method for identifying specific epitopes of Ag;  (9) in vitro cultured cells, human or animal, that have been treated with MAT, (I), the vector of (3) or vesicle of (5) and show modulated Ag presentation; and  (10) method for preparing antibodies (Ab), using MAT, (I), vesicles of (5), or cells of (4) or (9), by immunization.
Patent AU-2004207584-B2 (AU)
Title: Peelable overpouch films
Inventor: GOLLIER PAUL-ANDRE
IPC: B32B27/32
Filed: 2004-01-26
Granted: 2007-06-21
Abstract: The present invention provides a peelable polymeric layer structure having a first sealant layer including an ethylene-containing polymer, and a second sealant layer including a polypropylene-containing polymer attached to the first sealant layer along a peelable seal. The present invention also provides an overpouch container including a first sidewall having a first sealant layer of an ethylene-containing polymer, and a second sidewall having a second sealant layer of a propylene containing polymer. The second sealant layer is attached to the first sealant layer along a peelable peripheral seal.
Patent AU-2004213180-B2 (AU)
Title: Nitrate esters of phenylaminothiophenacetic acid derivatives
Inventor: FIGALA VOLKER
IPC: C07D333/36
Filed: 2004-02-17
Granted: 2010-06-03
Abstract: The compounds of formula I in which R1, R2, R3, R4 and R5 have the meanings as given in the description are novel effective antiinflammatory compounds.
Patent AU-2005251826-B2 (AU)
Title: Child safety seat, shell and harness
Inventor: MACIEJCZYK WIESLAW
IPC: B60R22/10
Filed: 2005-06-09
Granted: 2012-04-26
Abstract: A child safety seat arrangement wherein the child is secured to the safety seat by a harness (20). The harness (20) is then secured with respect to the vehicle by a mounting arrangement (26, 44) that is independent of any seat shell (30); preferably there is also a seat shell (30) that is itself secured with respect to the vehicle. Also disclosed is a child safety seat arrangement having a seat shell (30) with apertures (32, 32a) through which a harness (20) can be passed. The harness (20) preferably includes a main harness strap which is looped behind the seat shell, through a pair of apertures therein, to provide two shoulder straps to extend over a child’s shoulders. The disclosure also includes multiple pairs of apertures (32, 32a) to allow for adjustment of the height of the shoulder straps (20).